Delivery Order SPE2DB20D9214-SPE2DB24FD4VJ

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for use by the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract is a $46,732.08 firm fixed-price delivery order placed under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. Through this...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $18,397.58 to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) through the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract is a firm fixed-price agreement with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, a firm fixed-price delivery order worth $8,559.67, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, a multi-year indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $8,509.92 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a variety of pharmaceutical items, including injectable medications, tablets, creams, and specialty drugs, to support the medical supply needs of U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,368.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $11,840.66, is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The IDC,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $21,485.52 firm fixed-price delivery order contract has an ultimate completion date of September 13, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, involves the supply of a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The award, valued at $1,571.50, is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. This IDC, which runs...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4VJ
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group supplies a comprehensive range of routine and critical medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical prime vendor programs supporting military health facilities globally.

Generated 10/21/24, 9:38 AM